For non commercial use ONLY at the Maternal Sylvie Hauguel-de - - PowerPoint PPT Presentation

for non commercial use only
SMART_READER_LITE
LIVE PREVIEW

For non commercial use ONLY at the Maternal Sylvie Hauguel-de - - PowerPoint PPT Presentation

Lipid- -Immune crosstalk Immune crosstalk Lipid at the Maternal- -Fetal Interface Fetal Interface For non commercial use ONLY at the Maternal Sylvie Hauguel-de Mouzon, PhD Case Western Reserve University, Cleveland, USA What makes the


slide-1
SLIDE 1

Lipid Lipid-

  • Immune crosstalk

Immune crosstalk at the Maternal at the Maternal-

  • Fetal Interface

Fetal Interface

Sylvie Hauguel-de Mouzon, PhD Case Western Reserve University, Cleveland, USA

For non commercial use ONLY

slide-2
SLIDE 2

What makes the baby fat ?

Inflammation : the concepts

slide-3
SLIDE 3

Lean OW & Obese

p

Insulin (U/ml) 6.3 ± 3.7 14.3 ± 5.6

<0.001

Leptin (ng/ml) 13.1 ± 9.1 35.1 ± 20.5

0.001

IL-6 (ng/ml) 1.2 ± 0.4 3.2 ± 3.7

0.05

CRP(mg/dl) 0.4 ± 0.3 0.7 ± 0.4

0.03

TNF-alpha (pg/ml) Adiponectin (g/ml) 1.9 ± 1.3 11.6 ± 1.3 1.8 ± 0.8 8.4 ± 1.2

ns 0.001

Inflammatory Exposome in pregnancy with obesity

slide-4
SLIDE 4

macrophages invade the maternal adipose tissue and the placental stroma

CD 68 CD 68

PLACENTA ADIPOSE TISSUE

slide-5
SLIDE 5

PCA of all microbial communities

first trimester third trimester postpartum

  • bese
  • verweight

normal weight

2012 2012

slide-6
SLIDE 6

Cani & Delzenne 2009

inflammation inflammation inflammation

Dietary exposome impacts gut microbiota

LPS

slide-7
SLIDE 7

Lipopolysaccharide (LPS) structure

slide-8
SLIDE 8

TLR4

2006, Jason K. Kim

Toll-like Receptor 4 inflammatory signals

LPS

slide-9
SLIDE 9

plasma (EU/ml)

Increased LPS in maternal plasma in term Pregnancy

Basu, Hauguel-de Mouzon Obesity 2010

Obese Lean

0.0 0.50 1.0 0.25 0.75 p=0.004

slide-10
SLIDE 10

Toll Like Receptor 4 links innate immunity and fatty acid–induced insulin resistance Shi, Flier J. Clin. Invest. 2006 Fat uses a TOLL-road to connect inflammation and diabetes Kim J Cell Metab. 2006

The lipid-inflammation connection

slide-11
SLIDE 11

What makes the baby fat ?

Lipids – the concepts

slide-12
SLIDE 12

Hypothesis

Hyperlipemic envrionment at the maternal-fetal interface increases placental inflammation

slide-13
SLIDE 13

High plasma TG Fatty Acids Cholesterol (apoB)

Dietary exposome: lipids

saturated

slide-14
SLIDE 14

Meyer et al 2012

slide-15
SLIDE 15

Structural Similarity between LPS and Fatty Acids

FA

Oleic acid (C18:1) Palmitic acid (C16:0)

C14:0 C12:0

slide-16
SLIDE 16

TLR4 Toll-like Receptor 4 inflammatory signals

IL6-TNF-IL8

MyD88

NFB

CD14

LPS

Lipid A

Jason K. Kim, 2006 TLRs play a fundamental role in pathogen recognition and activation of innate immunity

Fatty Acid

slide-17
SLIDE 17

CONTROL PALMITATE 24hrs

Cytokeratine TLR4 HUMAN TERM PRIMARY TROPHOBLAST cells

slide-18
SLIDE 18

Can maternal lipid diet elicit placental inflammation

mono- unsaturated FA OLEATE C18:1 saturated FA PALMITATE C16:0

slide-19
SLIDE 19

TLR4 gene expression in cultured human trophoblast cells

4 8 12 16 CTL BSA LPS Oleate Palmitate (n=5)

mRNA fold change

1

slide-20
SLIDE 20

TLR4 activation in cultured human trophoblast cells

TLR4 mRNA fold change

Effect of LPS

1 2 3 4 CTL 6h 24h

*

5 10 15 20 CTL 6h 24h 1

* *

PALMITATE

slide-21
SLIDE 21

Inflammatory cytokine response to palmitate but not oleate in cultured trophoblast cells

mRNA fold change over CTL

(n=5)

1

15 30 45 60 IL-6 IL-8 TNF-a LPS Oleate Palmitate

slide-22
SLIDE 22

TLR4 Cytokeratin Dapi

m

Placenta TLR4 localization

slide-23
SLIDE 23

Yang, Hauguel-de Mouzon (ongoing studies)

Placenta TLR4 mRNA

2 4 6

Lean Obese

Fold change vs basal

slide-24
SLIDE 24

TOM Summary

2- LC-SAFA but not NSFA activate placental TLR4 inflammatory pathways 1- TLR4 inflammatory pathways are activated in placenta of obese women